Delivery Order SPE2DB24D2101-SPE2DB25FKNLK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Methylphenidate Extended-Release 36 mg tablets in quantities of 100 units. This contract, valued at $1,697.25, represents a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement running through December 2026. The delivery order was...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for methylphenidate extended-release 27 mg tablets (100 count) valued at $3,203.60, with completion targeted for August 1, 2025. This is a firm fixed-price delivery order issued with no set-aside designation, reflecting competitive procurement practices. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $1,690.77 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count bottles) on July 30, 2025, with completion scheduled for July 31, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order falls under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,992.32 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 27 mg tablets (100-count bottles) with a completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as...
- The Defense Logistics Agency awarded a delivery order valued at $1,128.17 to AmerisourceBergen Drug Corp for Methylphenidate ER 27 mg tablets (100-count supply) on June 9, 2025, with completion scheduled for June 10, 2025. This firm fixed-price delivery order was awarded without a set-aside designation through open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a $1,645.76 firm fixed price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Methylphenidate Extended Release 36 mg. The contract, awarded September 2, 2025, with completion targeted for September 3, 2025, represents a small-value pharmaceutical supply transaction without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order under its existing Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $1,116.64 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Methylphenidate ER 27 mg, with an ultimate completion date of July 15, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The contract was issued on July 14, 2025, and the place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,176.88 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 27 mg tablets (100-count) on May 6, 2025, with completion scheduled for May 7, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $2,884.88 to AmerisourceBergen Drug Corp for Methylphenidate Extended-Release 36 mg tablets (100-count supply). This firm fixed-price delivery order, issued on August 19, 2025, with completion targeted for August 20, 2025, represents a competitively awarded contract with no set-aside designation. The award will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Methylphenidate ER 27 mg, a controlled-release medication used to treat attention-deficit/hyperactivity disorder. This firm fixed-price delivery order, valued at $1,512.22, represents a non-set-aside, competitively awarded contract with an ultimate completion date of August 12, 2025. The order was fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKNLKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,121.70 to AmerisourceBergen Drug Corp for the supply of Methylphenidate Extended Release 27 mg tablets in a quantity of 100 units. This is a firm fixed price delivery order with no set-aside designation, executed on August 14, 2025, with an ultimate completion date of August 15, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The broader SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products, generic and brand-name medications, vaccines, and medical supplies to support military healthcare programs worldwide through the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA Troop Support Medical Supply Chain program leverages such prime vendor contracts to ensure consistent, reliable access to essential medications and medical commodities across the federal healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/14/25 |